Pediatrix Medical Group, Inc. (MD)
(Real Time Quote from BATS)
$7.77 USD
+0.06 (0.78%)
Updated Jun 21, 2024 10:52 AM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Brokerage Reports
Pediatrix Medical Group, Inc. [MD]
Reports for Purchase
Showing records 201 - 220 ( 341 total )
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Buyback to Offset Parity Headwind in 2015; Raising Estimates
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
2Q Beats by $0.01. 3Q14 Guidance In-Line. Outlook Remains Positive. Acquisitions, Parity Leverage Expected To Drive Earnings Growth. Affirm Buy Rating and $66PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Quick Alert: 2Q in Line as Revenue Growth Is Mostly Unchanged Q/Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Discontinuation of Research Coverage
Provider: FELTL & COMPANY
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Mixed quarterly results and a full valuation keep us on the sidelines
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Roll-Up Opportunity Offsets Tough Organic Environment
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Quick Alert: 1Q EPS in Line, Despite Weak Organic Trends
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Preliminary low weight birth data suggests inline 1Q14 trends
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Raising rating to Buy on steadier outlook
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Solid 4Q13 results with a bump from parity and rebound in NICU volumes
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
4Q Beats by $0.04. 1Q14 Guidance In-Line. Outlook Remains Positive. Acquisitions, Parity Leverage Expected To Drive Earnings Growth. Affirm Buy and $63 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Pediatrix Medical Group, Inc.
Industry: Medical - Hospital
Parity Likely Offers Upside in 2014, but Potential Headwind in 2015
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J